BMS 1611 (Baraclude 0.5 mg)
Generic Name: entecavir
Pill imprint BMS 1611 has been identified as Baraclude 0.5 mg.
Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- BMS 1611
- 0.5 mg
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
polyethylene glycol 400
|NDC Code||Manufacturer / Repackager|
|49884-0104||Par Pharmaceutical, Inc.|
Note: Inactive ingredients may vary.
More about Baraclude (entecavir)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.